Thirty days of rehab can be a real and worthwhile start, but for most people it isn't enough on its own. NIDA says most people need at least three months in treatment to significantly reduce or stop their use, and the best outcomes come with longer care (NIDA). Short programs tend to fall short when nothing follows them.
Let's be clear up front: this is not an argument against treatment. Detox, residential care, and medication can be lifesaving (NIDA Principles; Sordo et al., 2017). If you need them, go. This article is about what should come after, so the investment holds. If you're in danger now, call 911, call or text 988, or call the SAMHSA National Helpline at 1-800-662-4357.
Does short-term rehab work at all?
Yes, it can. A SAMHSA-commissioned review found that residential treatment shows value, with outcomes that were either better than or no different from other kinds of care (Reif et al., 2014). Intensive outpatient programs were about as effective as inpatient care for most people (McCarty et al., 2014).
The problem isn't the first 30 days. It's treating those 30 days as the whole cure. NIDA puts it plainly: medically assisted detox is "only the first stage of addiction treatment," and detox alone is rarely enough for long-term recovery (NIDA Principles).
Where did the 28- or 30-day program come from?
According to NIDA, short-term residential programs grew out of a model built for alcohol problems. That model was a 3- to 6-week hospital-based inpatient phase, followed by extended outpatient therapy and participation in a self-help group such as AA (NIDA Principles). The short stay was designed as the opening phase of a longer plan, not the entire plan.
Over time, addiction care has often been treated like an acute illness: a short episode of care, then discharge. In a JAMA review, researchers compared drug dependence with diabetes, hypertension, and asthma. They found similar heritability, similar rates of relapse and medication adherence, and they argued addiction "should be insured, treated, and evaluated like other chronic illnesses," with long-term monitoring (McLellan et al., 2000). How insurance and funding shaped program lengths will get its own article in this series.
What does the research say about length of stay?
A few definitions first:
- Length of stay is how long a person stays in a treatment program, whether residential, outpatient, or medication-based.
- Continuing care (or aftercare) is lower-intensity support that keeps going after an intensive program ends: outpatient sessions, check-ins, recovery housing, mutual-help groups, or ongoing medication.
Here's what the evidence suggests:
- About 90 days is a minimum, not a finish line. NIDA says that for residential or outpatient treatment, participation of less than 90 days is of limited effectiveness, and that longer treatment is recommended. For methadone, NIDA considers 12 months the minimum (NIDA Principles).
- Staying longer predicts better outcomes. In one study of methadone patients, those who stayed in treatment a year or longer were nearly five times more likely to have better outcomes after discharge (Simpson et al., 1997). In therapeutic communities, length of stay and aftercare consistently predicted recovery (Vanderplasschen et al., 2013).
- Recovery is usually measured in years. In a study of 1,271 people in a large U.S. city in publicly funded treatment, the median time from first use to last use was 27 years, and from first treatment to last use was 9 years. Multiple episodes of care were the norm (Dennis et al., 2005).
A 30-day program set against a multi-year illness is a short chapter. It's an important chapter, but it isn't the whole book.
Why do 30/60/90-day programs often fall short?
- The calendar decides instead of the person. The ASAM Criteria are designed so that admission, continued stay, and transfer are based on a multidimensional assessment of each patient (ASAM). A fixed 30-, 60-, or 90-day package can end before someone is ready.
- People go home to the same triggers. NIDA lists stress, cues linked to past use (people, places, things, and moods), and contact with drugs as the most common relapse triggers (NIDA). Discharge often means walking straight back into all three.
- Aftercare is thin or missing. Continuing care shows a small but significant benefit overall (Blodgett et al., 2014), and longer care with active efforts to keep people engaged may work more consistently (McKay, 2021). When nobody follows up, that benefit is lost.
- Lost tolerance raises overdose risk. After a period without use, the body isn't adapted to the old dose, and returning to it can easily cause an overdose (NIDA). One Norwegian study found sharply higher overdose deaths in the first four weeks after people left medication-free inpatient treatment. All of those deaths were among people who had dropped out (Ravndal & Amundsen, 2010). For opioid use disorder, ask about medication and naloxone before discharge (NIDA).
- People leave early. NIDA notes that people often leave treatment prematurely, so programs need ways to keep them engaged (NIDA Principles).
What does good continuing care look like?
| Program-only approach | Continuing-care approach | |
|---|---|---|
| How long it lasts | Ends on a set date (30, 60, or 90 days) | Months to years, stepping down in intensity |
| Who decides it's done | The calendar or the benefit limit | Ongoing assessment of the person (ASAM) |
| What happens after discharge | Sometimes only a referral list | Scheduled outpatient care, check-ins, and community support |
| How relapse is handled | Sometimes treated as failure | A signal to resume or adjust care (NIDA) |
| Medication for opioid use | May be stopped at discharge | Continued as long as it helps; methadone for 12 months at minimum (NIDA Principles) |
| Evidence | Limited when under 90 days (NIDA Principles) | Modest but real benefits (Blodgett et al., 2014) |
One tested model is the recovery management checkup: quarterly check-ins with quick re-linkage to treatment when needed. In two randomized trials, adults who got these checkups did better than controls. The effects were larger in the second trial, where they got back into treatment sooner and had more days abstinent over two years (Scott & Dennis, 2009). Recovery housing and mutual-help groups can carry the same idea into everyday life (Reif et al., 2014; Cochrane, 2020).
How do you plan for life after a 30-day program?
- Start planning in week one. Ask the program, "What's the plan for day 31?"
- Ask for a step-down. Ask about outpatient or intensive outpatient care right after discharge, based on an assessment.
- Keep your medication plan. If you're on medication for opioid or alcohol use disorder, make sure the prescription and follow-up appointment are set before you leave. Never stop medication without your prescriber.
- Know your overdose risk. Learn about naloxone and keep it where your family can find it.
- Line up community. Choose meetings for your first week home: 12-step, faith-based, or peer support.
- Check your housing. If home isn't safe for sobriety, look into recovery housing.
- Write a relapse prevention plan. Use What Are the Warning Signs of Relapse? to list your signs and responses.
- Schedule check-ins. Put monthly or quarterly check-ins on the calendar for at least a year.
What should you ask a program before you enroll?
Whether the stay is 30 days or 90, these questions can help you tell a program that plans for recovery from one that plans for discharge:
- "How do you decide how long I stay?" Listen for an assessment-based answer, like the ASAM Criteria, rather than a fixed package (ASAM).
- "What happens on day 31?" Ask to see a written continuing-care plan with named outpatient providers, dates, and check-ins.
- "Do you support medication for opioid or alcohol use disorder?" For opioid addiction, NIDA calls medication the first line of treatment, usually with counseling (NIDA). A program shouldn't make you stop a medication that's working.
- "Will I leave with naloxone and overdose education?" That matters because of lost tolerance (NIDA).
- "What do you do if I relapse?" Look for re-engagement and adjusted care, not just discharge (NIDA).
- "Who else can I check you with?" Look the program up yourself on FindTreatment.gov, or call the SAMHSA Helpline, instead of relying on an ad or a call center (FindTreatment.gov).
Where does a free peer-support ministry fit?
Recovering Addict isn't a treatment center, and we don't replace medical care. We're one of the places people can keep showing up long after a program ends, for free. We offer peer support from a team certified in relapse prevention (Terence Gorski model). "Bear one another's burdens, and so fulfill the law of Christ" (Galatians 6:2, WEB).
We meet Monday, Wednesday, and Friday from 6 to 8 p.m. at Iron House Gym, 155 W 14th Street, Ogden. Learn about the program, plan your first visit, or contact us. To compare treatment types side by side, read Does Rehab Work? What Actually Works in Addiction Recovery.
Is there a workbook for the months after rehab?
If you want structured work for the long stretch after a program, the Christ-centered 12-step workbook series, written by Leonard Ted Weaver, is an optional companion to community and care:
Coming home from a program? Call or text 801-695-3085 (not staffed around the clock), or join us at a meeting. Start with your first visit. In a crisis, call or text 988.
Recovery questions answered
Is 30 days of rehab enough?
For most people, not by itself. NIDA says less than 90 days of residential or outpatient treatment is of limited effectiveness (NIDA Principles). A 30-day stay works best as the first step of a longer plan.
Is 90-day rehab better than 30-day rehab?
Evidence suggests longer engagement predicts better outcomes (NIDA Principles). That doesn't have to mean 90 days in residence. Stepping down to outpatient care and community support can count.
Why do people relapse right after rehab?
Common reasons include going home to the same triggers, thin aftercare, and leaving early (NIDA). Lost tolerance makes a return to use especially dangerous.
Should I skip a 30-day program if that's all I can get?
No. Take the care that's available, and plan what comes next. Detox and short-term treatment can be lifesaving first steps (NIDA Principles).
What is continuing care?
It's lower-intensity support after an intensive program, such as outpatient sessions, check-ins, recovery housing, or mutual-help groups. Reviews find modest but real benefits (Blodgett et al., 2014).
How long does recovery take?
Often years. In one long-term study, the median time from first treatment to last use was 9 years, and multiple episodes of care were common (Dennis et al., 2005).
Sources
- Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). National Institute on Drug Abuse (NIDA).
- Drugs, Brains, and Behavior: The Science of Addiction. Treatment and Recovery. National Institute on Drug Abuse (NIDA).
- Naloxone DrugFacts. National Institute on Drug Abuse (NIDA).
- McLellan AT, et al. (2000). Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA (via PubMed).
- Reif S, et al. (2014). Residential treatment for individuals with substance use disorders: assessing the evidence. Psychiatric Services (via PubMed).
- McCarty D, et al. (2014). Substance abuse intensive outpatient programs: assessing the evidence. Psychiatric Services (via PubMed Central).
- Simpson DD, Joe GW, Rowan-Szal GA. (1997). Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence (via PubMed).
- Vanderplasschen W, et al. (2013). Therapeutic communities for addictions: a review of their effectiveness from a recovery-oriented perspective. The Scientific World Journal (via PubMed Central).
- Dennis ML, et al. (2005). The duration and correlates of addiction and treatment careers. Journal of Substance Abuse Treatment (via PubMed).
- Blodgett JC, et al. (2014). How effective is continuing care for substance use disorders? A meta-analytic review. Journal of Substance Abuse Treatment (via PubMed Central).
- McKay JR. (2021). Impact of continuing care on recovery from substance use disorder. Alcohol Research: Current Reviews (via PubMed Central).
- Scott CK, Dennis ML. (2009). Results from two randomized clinical trials evaluating the impact of quarterly recovery management checkups. Addiction (via PubMed Central).
- Ravndal E, Amundsen EJ. (2010). Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study. Drug and Alcohol Dependence (via PubMed).
- Reif S, et al. (2014). Recovery housing: assessing the evidence. Psychiatric Services (via PubMed).
- Kelly JF, Humphreys K, Ferri M. (2020). Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database of Systematic Reviews (via PubMed Central).
- About the ASAM Criteria. American Society of Addiction Medicine (ASAM).
- SAMHSA's National Helpline, 1-800-662-HELP (4357). SAMHSA.
- Sordo L, et al. (2017). Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis. BMJ (via PubMed Central).
- FindTreatment.gov. SAMHSA.
